Zahra Kassamali Escobar
Overview
Explore the profile of Zahra Kassamali Escobar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hartlage W, Castillo A, Kassamali Escobar Z, Bajenov M, Martinez-Paz N, Lynch J, et al.
Antimicrob Steward Healthc Epidemiol
. 2025 Mar;
5(1):e49.
PMID: 40026777
We evaluated 249 asymptomatic patients receiving antibiotics for urinary infection: 222 had asymptomatic pyuria and/or nitrituria (ASPN) and 133 had asymptomatic bacteriuria (ASB, growth ≥10 colony forming units/ml). ASPN identified...
2.
Imlay H, Ciarkowski C, Bryson-Cahn C, Chan J, Hartlage W, Hersh A, et al.
Infect Control Hosp Epidemiol
. 2024 Dec;
:1-6.
PMID: 39676688
Objective: Inappropriate diagnosis and treatment of urinary tract infections (UTIs) contribute to antibiotic overuse. The Inappropriate Diagnosis of UTI (ID-UTI) measure uses a standard definition of asymptomatic bacteriuria (ASB) and...
3.
Ciarkowski C, Imlay H, Bryson-Cahn C, Chan J, Hartlage W, Hersh A, et al.
Infect Control Hosp Epidemiol
. 2024 Nov;
:1-7.
PMID: 39523519
Background: Asymptomatic bacteriuria (ASB) treatment is a common form of antibiotic overuse and diagnostic error. Antibiotic stewardship using the inappropriate diagnosis of urinary tract infection (ID-UTI) measure has reduced ASB...
4.
Sanchez E, Krantz E, Kassamali Escobar Z, Tverdek F, Rosen E, Ueda Oshima M, et al.
Open Forum Infect Dis
. 2024 Oct;
11(10):ofae570.
PMID: 39450393
Background: There are limited data on the contemporary epidemiology of recurrent infection (CDI) among hematopoietic cell transplant (HCT) recipients. We aimed to determine the incidence, risk factors, and outcomes for...
5.
Rosen E, Krantz E, McCulloch D, Wilson M, Tverdek F, Kassamali Escobar Z, et al.
Transplant Cell Ther
. 2024 Aug;
30(11):1108.e1-1108.e11.
PMID: 39179107
Recipients of cellular therapies, including hematopoietic cell transplant (HCT) and chimeric antigen receptor T-cell (CART) therapy, are at risk for poor outcomes from coronavirus disease 2019 (COVID-19). There are limited...
6.
Lau J, Huang J, Kassamali Escobar Z
Open Forum Infect Dis
. 2024 Jun;
11(6):ofae258.
PMID: 38933740
No abstract available.
7.
Sanchez E, Krantz E, Yoke L, Gallaher M, Bhattacharyya P, So L, et al.
Transpl Infect Dis
. 2024 Jan;
26(1):e14223.
PMID: 38191852
Background: There are limited data on clinical outcomes associated with the use of bebtelovimab for the treatment of coronavirus disease 2019 (COVID-19) among cancer patients. We aimed to define the...
8.
Hartlage W, Bryson-Cahn C, Castillo A, Jain R, Lynch J, Martinez-Paz N, et al.
Infect Control Hosp Epidemiol
. 2023 Nov;
45(3):380-383.
PMID: 37929617
We evaluated the prevalence and treatment of asymptomatic bacteriuria (ASB) in 17 critical-access hospitals. Among 891 patients with urine cultures from September 2021 to June 2022, 170 (35%) had ASB....
9.
Kassamali Escobar Z, Shively N
Infect Dis Clin North Am
. 2023 Sep;
37(4):873-900.
PMID: 37657974
Tele-antimicrobial stewardship programs (tele-ASPs) use technology and remote access to resources and clinical expertise to expand antimicrobial services within and outside of health systems. Models of tele-ASPs are workforce multiplying...
10.
Tverdek F, Kassamali Escobar Z, Liu C, Jain R, Lindsay J
Transpl Infect Dis
. 2023 Aug;
25 Suppl 1:e14129.
PMID: 37594221
Background: Appropriate use of antimicrobials for hematologic malignancy, hematopoietic stem cell transplant recipients, and other cellular therapies is vital, with infection causing significant morbidity and mortality in this unique population...